Health Experimental Lung Cancer Drug Shows 34% Reduction in Death Risk May 31, 2026 Breakthrough Results in Squamous Non-Small-Cell Lung Cancer An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a closely watched late-stage trial.…